DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians
(2025)
Journal Article
Malyszko, J., De Seigneux, S., Cantaluppi, V., Faguer, S., Gameiro, J., Lopes, J. A., Sanz Bartolome, A., Saritas, T., Selby, N. M., & Ostermann, M. (2025). DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction -Implications for clinicians. Nephrology Dialysis Transplantation, https://doi.org/10.1093/ndt/gfaf013